Showing results (131-140 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Pathology|January 13, 2011
Determining prostate cancer-specific death through quantification of stromogenic carcinoma area in prostatectomy specimensGustavo E Ayala, Bahar Muezzinoglu, Kai H Hammerich, et al.
The Journal of Clinical Investigation|February 15, 2021
MAPK4 promotes prostate cancer by concerted activation of androgen receptor and AKTTao Shen, Wei Wang, Wolong Zhou, et al.
Cancer Research|December 6, 2013
FGFR1-WNT-TGF-β signaling in prostate cancer mouse models recapitulates human reactive stromaJulienne L Carstens, Payam Shahi, Susan Van Tsang, et al.
Molecular Cancer Therapeutics|October 31, 2013
BAY 80-6946 is a highly selective intravenous PI3K inhibitor with potent p110α and p110δ activities in tumor cell lines and xenograft modelsNingshu Liu, Bruce R Rowley, Cathy O Bull, et al.
Neoplasia (New York, N.Y.)|April 24, 2017
A Versatile Tumor Gene Deletion System Reveals a Crucial Role for FGFR1 in Breast Cancer MetastasisWei Wang, Yanling Meng, Bingning Dong, et al.
Cancer Cell|November 14, 2018
The Osteogenic Niche Is a Calcium Reservoir of Bone Micrometastases and Confers Unexpected Therapeutic VulnerabilityHai Wang, Lin Tian, Jun Liu, et al.
The Plant Journal : for Cell and Molecular Biology|May 27, 2016
The genome of black raspberry (Rubus occidentalis)Robert VanBuren, Doug Bryant, Jill M Bushakra, et al.
Molecular Cancer Therapeutics|July 5, 2006
Constitutively active receptor tyrosine kinases as oncogenes in preclinical models for cancer therapeuticsKristen A Kellar, Matthew V Lorenzi, Ching Ping Ho, et al.
Journal of Medicinal Chemistry|May 9, 1998
Synthesis and pharmacology of conformationally restricted raloxifene analogues: highly potent selective estrogen receptor modulatorsT A Grese, L D Pennington, J P Sluka, et al.
British Journal of Anaesthesia|July 25, 2020
A restrictive versus liberal transfusion strategy to prevent myocardial injury in patients undergoing surgery for fractured neck of femur: a feasibility randomised trial (RESULT-NOF)Michael A Gillies, Sadia Ghaffar, Iain K Moppett, et al.
Pageof 15